Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Mapping DNA Methylation Signatures to Identify Epigenetic Variation Across Subcortical Regions of the Human Posttraumatic Stress Disorder Brain.

Biological psychiatry·2025
Same author

A multi-omic approach implicates novel protein dysregulation in post-traumatic stress disorder.

Genome medicine·2025
Same author

The endogenous opioid system in the medial prefrontal cortex mediates ketamine's antidepressant-like actions.

Translational psychiatry·2024
Same author

Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in mice.

Neuropsychopharmacology reports·2023
Same author

M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2023
Same author

Influence of Chronic Electroconvulsive Seizures on Plasticity-Associated Gene Expression and Perineuronal Nets Within the Hippocampi of Young Adult and Middle-Aged Sprague-Dawley Rats.

The international journal of neuropsychopharmacology·2023

関連する実験動画

Updated: May 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

うつ病におけるシナプス機能障害:潜在的な治療目標

Ronald S Duman1, George K Aghajanian

  • 1Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT 06508, USA. ronald.duman@yale.edu

Science (New York, N.Y.)
|October 9, 2012
PubMed
まとめ
この要約は機械生成です。

ケタミンは,従来の抗うつ剤とは異なり,脳細胞間の新しい接続を促進することによって,うつ病を迅速に逆転させます. この発見は,うつ病の治療をニューロンシナプスの成長と結びつける新しい理論を支持する.

さらに関連する動画

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
09:10

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density

Published on: July 22, 2022

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

関連する実験動画

Last Updated: May 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
09:10

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density

Published on: July 22, 2022

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

科学分野:

  • 神経科学は神経科学である.
  • 精神科医は精神病を患っている.
  • 薬理学 薬理学とは

背景:

  • うつ病は,気分と認知を調節する小さな脳領域と関連しており,ニューロンの接続が少ない.
  • 伝統的な抗うつ剤は,発作が遅い,有効性が限られている.

研究 の 目的:

  • ケタミンの迅速な抗うつ効果を調査するために.
  • ケタミンの神経シナプスへの作用の根本的なメカニズムを探求する.

主な方法:

  • うつ病と抗うつ薬の治療に関する基本的および臨床研究のレビュー.
  • ケタミンがN-メチル-D-アスパルテート受容体とシナプトゲネシスに及ぼす影響の分析.

主要な成果:

  • ケタミンは,N-メチル-D-アスパルテート受容体の抗体であり,治療に抵抗性のある患者に数時間以内に迅速な抗うつ効果を提供します.
  • ケタミンはすぐにシナプトゲネシスを誘発し,ストレス誘発のシナプス欠陥を逆転させます.

結論:

  • ケタミンの急速な抗うつ作用は,シナプトゲネシスによって媒介されます.
  • これらの発見は,うつ病と治療への反応に関するシナプトジェニック仮説を支持し,気分回路接続の重要性を強調しています.